Literature DB >> 14980033

Results of laparoscopic gastric bypass in patients with cirrhosis.

Ramsey M Dallal1, Samer G Mattar, Jeffrey L Lord, Andrew R Watson, Daniel R Cottam, George M Eid, Giselle Hamad, Mordecai Rabinovitz, Philip R Schauer.   

Abstract

BACKGROUND: The safety and efficacy of bariatric surgery in patients with cirrhosis has not been well studied.
METHODS: A retrospective review was conducted of patients with cirrhosis who underwent weight-loss surgery at a single institution.
RESULTS: Out of a total of 2119 patients who underwent laparoscopic Roux-en-Y gastric bypass (RYGBP), 30 patients (1.4%) with cirrhosis were identified. When compared with the entire cohort, patients with cirrhosis were significantly more prone to be heavier (BMI 53 vs 48), older in years (age 50 vs 45), more likely to be male (RR=1.3), and have a higher incidence of diabetes (70% vs 21%) and hypertension (67% vs 21%), P<0.05. The diagnosis of cirrhosis was made intra-operatively in 90% of patients. There were no perioperative deaths, conversions to laparotomy, or liver-related complications. Early complications occurred in 9 patients and included anastomotic leak (1), acute tubular necrosis (4), prolonged intubation (2), ileus (1), and blood transfusion (2). Mean length of hospital stay was 4 days (2-18). There was one late unrelated death and one patient with prolonged nausea and protein malnutrition. The average follow-up time was 16 months (1-48). For patients >12 months postoperatively (n=15), the average percent excess weight loss was 63+/-15%.
CONCLUSION: Laparoscopic RYGBP in the cirrhotic patient has an acceptable complication rate and achieves satisfactory early weight loss. Patients tend to be heavier, older, male and more likely to have diabetes and hypertension. Long-term studies are necessary to examine how weight loss impacts established cirrhosis.

Entities:  

Mesh:

Year:  2004        PMID: 14980033     DOI: 10.1381/096089204772787284

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  39 in total

Review 1.  Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Melanie D Beaton
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

2.  Outcomes of Bariatric Surgery in Patients with Cirrhosis.

Authors:  Inka Miñambres; Miguel Angel Rubio; Ana de Hollanda; Irene Breton; Nuria Vilarrasa; Silvia Pellitero; Marta Bueno; Albert Lecube; Clara Marcuello; Albert Goday; Maria D Ballesteros; German Soriano; Assumpta Caixàs
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

3.  Hepatic decompensation after gastric bypass surgery for severe obesity.

Authors:  Scott J Cotler; Joseph M Vitello; Grace Guzman; Giuliano Testa; Enrico Benedetti; Thomas J Layden
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 4.  [Evidential basis in bariatric surgery].

Authors:  M K Müller; S Wildi; P-A Clavien; M Weber
Journal:  Chirurg       Date:  2005-07       Impact factor: 0.955

Review 5.  Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery.

Authors:  Andrea Lazzati; Antonio Iannelli; Anne-Sophie Schneck; Anaïs Charles Nelson; Sandrine Katsahian; Jean Gugenheim; Daniel Azoulay
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

Review 6.  Management of nonalcoholic fatty liver disease: Role of bariatric surgery.

Authors:  Julia Wattacheril; Naga Chalasani
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-09-25

Review 7.  Bariatric Surgery in the Peritransplant Period.

Authors:  Sydney Pomenti; Sanket Mehta; Averill Guo; Julia Wattacheril
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

Review 8.  Considerations for bariatric surgery in patients with cirrhosis.

Authors:  George Boon-Bee Goh; Philip R Schauer; Arthur J McCullough
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 9.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

10.  Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.

Authors:  Dima L Diab; Lisa Yerian; Philip Schauer; Sangeeta R Kashyap; Rocio Lopez; Stanley L Hazen; Ariel E Feldstein
Journal:  Clin Gastroenterol Hepatol       Date:  2008-07-26       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.